Janus Henderson Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.15M Sell
51,410
-238,701
-82% -$5.7M ﹤0.01% 1635
2025
Q4
$7.75M Buy
290,111
+238,701
+464% +$5.7M ﹤0.01% 807
2025
Q3
$1.1M Buy
51,410
+8,286
+19% +$196K ﹤0.01% 1615
2025
Q2
$930K Sell
43,124
-382,779
-90% -$7.11M ﹤0.01% 1655
2025
Q1
$7.27M Buy
425,903
+373,079
+706% +$6.78M ﹤0.01% 778
2024
Q4
$970K Hold
52,824
﹤0.01% 1704
2024
Q3
$813K Hold
52,824
﹤0.01% 1776
2024
Q2
$858K Sell
52,824
-832
-2% -$13.4K ﹤0.01% 1701
2024
Q1
$991K Buy
53,656
+2
+0% +$50 ﹤0.01% 1646
2023
Q4
$1.68M Sell
53,654
-124
-0.2% -$2.96K ﹤0.01% 1336
2023
Q3
$1.12M Buy
53,778
+12
+0% +$326 ﹤0.01% 1501
2023
Q2
$1.29M Buy
53,766
+168
+0.3% +$3.73K ﹤0.01% 1474
2023
Q1
$1.01M Buy
53,598
+29,217
+120% +$556K ﹤0.01% 1626
2022
Q4
$388K Sell
24,381
-24,383
-50% -$381K ﹤0.01% 1846
2022
Q3
$796K Buy
48,764
+24,065
+97% +$390K ﹤0.01% 1748
2022
Q2
$348K Sell
24,699
-2,270,577
-99% -$42.4M ﹤0.01% 1985
2022
Q1
$55.6M Buy
2,295,276
+258,295
+13% +$6.25M 0.03% 464
2021
Q4
$47.5M Buy
2,036,981
+85,123
+4% +$1.71M 0.02% 560
2021
Q3
$32.4M Buy
1,951,858
+22,727
+1% +$438K 0.01% 671
2021
Q2
$47.1M Sell
1,929,131
-3,448,245
-64% -$77.8M 0.02% 577
2021
Q1
$139M Buy
5,377,376
+294,464
+6% +$13M 0.06% 295
2020
Q4
$272M Sell
5,082,912
-623,192
-11% -$30.9M 0.13% 173
2020
Q3
$235M Buy
5,706,104
+1,796,141
+46% +$77.6M 0.12% 177
2020
Q2
$190M Buy
3,909,963
+2,420,061
+162% +$116M 0.11% 201
2020
Q1
$62.9M Buy
+1,489,902
New +$61.4M 0.04% 392
2019
Q4
Sell
-103,894
Closed -$3.74M 1413
2019
Q3
$3.74M Buy
+103,894
New +$3.15M ﹤0.01% 1092
2019
Q1
Sell
-3,142,042
Closed -$50.8M 1343
2018
Q4
$50.8M Sell
3,142,042
-742
-0% -$14.4K 0.03% 534
2018
Q3
$65.2M Sell
3,142,784
-305,826
-9% -$4.81M 0.03% 514
2018
Q2
$52.7M Sell
3,448,610
-3,546,991
-51% -$63.2M 0.03% 540
2018
Q1
$157M Buy
6,995,601
+214,317
+3% +$5.93M 0.09% 256
2017
Q4
$204M Buy
6,781,284
+822,736
+14% +$26.3M 0.12% 203
2017
Q3
$224M Buy
5,958,548
+2,295,881
+63% +$74.7M 0.14% 196
2017
Q2
$102M Buy
+3,662,667
New +$109M 0.07% 350

Other funds holding ACAD